Abstract
The term “idiopathic pulmonary fibrosis” (IPF) began to appear in the medical literature in the mid-1900s and was initially used by clinicians and radiologists to refer to fibrosing pneumonitis of unknown cause. However, the entities that we now recognize as idiopathic interstitial pneumonias (IIPs) and other entities with similar clinical presentations, such as interstitial lung disease (ILD) associated with connective tissue disorders (CTD) or fibrotic hypersensitivity pneumonitis (HP), were often identified as cases of IPF by clinicians due to similar clinical presentation and radiographic appearance. As our knowledge of fibrosing ILD expanded over the last three decades of the twentieth century, it became clear that histopathologic patterns could be found that paved the way to our current clinicopathologic classification of the IIPs, with the term “IPF” used exclusively to designate patients with idiopathic usual interstitial pneumonia (UIP). This introductory chapter will review how terminology and concepts of the disorder that we now recognize as IPF have evolved over the decades such that IPF has become the preferred diagnostic term for patients diagnosed with UIP of unknown cause.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSuggested Readings
American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000;161(2 Pt 1):646–64.
American Thoracic Society; European Respiratory Society. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med. 2002;165(2):277–304.
Ander L. Idiopathic interstitial fibrosis of the lungs. I. Prognosis as indicated by radiological findings. Acta Med Scand. 1965;178:47–58.
Brown CH, Turner-Warwick M. The treatment of cryptogenic fibrosing alveolitis with immunosuppressant drugs. Q J Med. 1971;40(158):289–302.
George TJ, Arnaoutakis GJ, Shah AS. Lung transplant in idiopathic pulmonary fibrosis. Arch Surg. 2011;146(10):1204–9.
Gottlieb AJ, Spiera H, Teirstein AS, Siltzbach LE. Serologic factors in idiopathic diffuse interstitial pulmonary fibrosis. Am J Med. 1965;39:405–10.
Hamman L, Rich AR. Fulminating diffuse interstitial fibrosis of the lungs. Trans Am Clin Climatol Assoc. 1935;51:154–63.
Hugh-Jones P, Macarthur AM, Cullum PA, Mason SA, Crosbie WA, Hutchison DC, et al. Lung transplantation in a patient with fibrosing alveolitis. Br Med J. 1971;3(5771):391–8.
Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu G, Anstrom KJ, King Jr TE, Lasky JA, Martinez FJ. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012;366(21):1968–77.
Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol. 1994;18(2):136–47.
Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998;157(4 Pt 1):1301–15.
Liebow AA. Definition and classification of interstitial pneumonias in human pathology. Prog Respir Res. 1975;8:1–31.
Malmberg R, Berglund E, Ander L. Idiopathic interstitial fibrosis of the lungs. II. Reversibility of respiratory disturbances during steroid administration. Acta Med Scand. 1965;178:59–66.
Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004–14.
Montgomery CH. Idiopathic interstitial pulmonary fibrosis (Hamman-Rich syndrome): report of a case and survey of the literature. Harv Dent Alumni Bull. 1964;19:48–68.
Nathan SD, Shlobin OA, Weir N, Ahmad S, Kaldjob JM, Battle E, et al. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest. 2011;140(1):221–9.
Peikert T, Daniels CE, Beebe TJ, Meyer KC, Ryu JH, Interstitial Lung Diseases Network of the American College of Chest Physicians. Assessment of current practice in the diagnosis and therapy of idiopathic pulmonary fibrosis. Respir Med. 2008;102(9):1342–8.
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.
Raghu G, Depaso WJ, Cain K, Hammar SP, Wetzel CE, Dreis DF, et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis. 1991;144(2):291–6.
Reid JM, Cuthbert J, Craik JE. Chronic diffuse idiopathic fibrosing alveolitis. Br J Dis Chest. 1965;59(4):194–201.
Robbins LL. Idiopathic pulmonary fibrosis; roentgenologic findings. Radiology. 1948;51(4):459–67.
Sheridan LA, Harrison Jr EG, Divertie MB. The current status of idiopathic pulmonary fibrosis (Hamman-Rich syndrome). Med Clin North Am. 1964;48:993–1010.
Stack BH, Choo-Kang YF, Heard BE. The prognosis of cryptogenic fibrosing alveolitis. Thorax. 1972;27(5):535–42.
Stack BH, Grant IW, Irvine WJ, Moffat MA. Idiopathic diffuse interstitial lung disease. A review of 42 cases. Am Rev Respir Dis. 1965;92(6):939–48.
Wildevuur CR, Benfield JR. A review of 23 human lung transplantations by 20 surgeons. Ann Thorac Surg. 1970;9(6):489–515.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Meyer, K.C. (2014). Idiopathic Pulmonary Fibrosis: A Historical Perspective. In: Meyer, K., Nathan, S. (eds) Idiopathic Pulmonary Fibrosis. Respiratory Medicine, vol 9. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-682-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-62703-682-5_1
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-681-8
Online ISBN: 978-1-62703-682-5
eBook Packages: MedicineMedicine (R0)